SFT — Sopharma Trading AD Cashflow Statement
0.000.00%
Last trade - 00:00- €115.85m
- €253.80m
- €1.18bn
Annual cashflow statement for Sopharma Trading AD, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Changes in Working Capital | -42.1 | -42.2 | -47.7 | -61 | -75.2 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -88.5 | 9.5 | 24.5 | 35.2 | -2.12 |
| Capital Expenditures | -6.55 | -4.72 | -7.59 | -9.5 | -11 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.771 | -1.49 | -5.6 | -5.03 | 0.197 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.32 | -6.21 | -13.2 | -14.5 | -10.8 |
| Financing Cash Flow Items | 98.6 | 15.6 | 0.169 | -0.043 | -0.001 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 98 | -5.77 | -8.12 | -20.4 | 13.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.26 | -2.49 | 3.21 | 0.29 | 0.861 |